The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C in Brazil

Campos, Karoline Rodrigues; Alves, Fabiana Aparecida; Lemos, Marcílio Figueiredo; Moreira, Regina Célia; Marcusso, Rosa Maria Nascimento; Araújo, Adele Caterino.
PLoS negl. trop. dis ; 14(5): 0008245, May 2020. tab, ilus
Artigo Inglês | SES-SP, SES SP - Instituto Adolfo Lutz, SES-SP, SES SP - Acervo Instituto Adolfo Lutz, SES SP - Instituto de Infectologia Emílio Ribas, SES-SP | ID: biblio-1100279

Documentos relacionados

  1. The importance of confirmatory assays in testing blood donors for human T-cell lymphotropic virus.
  2. Evaluation of human T-cell leukemia virus in vitro diagnostics using plasma specimens collected in Japan.
  3. A Panel of Eight miRNAs Is Deregulated in HTLV-2 Infected PBMCs and BJABGu Cell Line.
  4. Human T-lymphotropic virus in Irish blood donors: Impact on future testing strategy.
  5. The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C in Brazil.
  6. Low risk of human T-lymphotropic virus infection in U.S. blood donors; Is it time to consider a one-time selective testing approach?
  7. Comparison of two new HTLV-I/II screening methods, Abbott Alinity i rHTLV-I/II and Diasorin LIAISON® XL murex recHTLV-I/II, to Abbott architect rHTLVI/II assay.
  8. [Investigation of HTLV-I/II Seroprevalance of Patients with HIV Positivity being Monitored by Real-Time RT-PCR].
  9. Epidemiological and clinical aspects of human T-cell leukemia virus infection types 1 and 2: an introduction.
  10. Line Immunoassay for Confirmation and Discrimination of Human T-Cell Lymphotropic Virus Infections in Inconclusive Western Blot Serum Samples from Brazil.